The cancer light immunotherapy, done in the near infrared (NIR-PIT), is developed at Shimadzu by Hisataka KOBAYASHI and will be further developed with US National Cancer Institute.
Shimadzu news release, January 15, 2018
Shimadzu launches collaboration with NCI on cancer light immunotherapy